Dr. Julie M. Collins, MD, MPH

Dr. Julie M. Collins, MD, MPH

Dr. Julie M. Collins, MD, MPH

Languages: English

Contact this Provider:

  • Breast Medical Oncology
Conditions I Treat
  • atypical ductal hyperplasia
  • brca
  • breast cancer
  • breast cancer during pregnancy
  • breast cancer in young women
  • Show All
Procedures I Perform
  • adjuvant chemotherapy
  • breast cancer chemotherapy
  • breast cancer follow up
  • breast cancer genetics
  • chemoradiation
  • Show All
About the Provider

Julie M Collins, MD, MPH, is a fellowship-trained, board-certified medical oncologist. She specializes in diagnosing and treating all types of breast cancer (hormone receptor-positive, triple-negative, and HER2-positive) and carcinoma in situ of the breast. She offers patients advanced and highly specialized care, including chemotherapy, chemoimmunotherapy, targeted therapies, immunotherapy, endocrine therapies, and clinical trials. Dr. Collins has experience with phase I, II, and III clinical trials. Dr. Collins’ research focuses on the development of novel therapies for patients with breast cancer, specifically immunotherapies and therapies to overcome endocrine resistance.

Dr. Collins’ Philosophy of Care:

"I approach each patient from a humanistic perspective, considering not only their diagnosis but also who they are as a person. I seek to understand each patient’s goals and hopes while incorporating both standard therapies and novel approaches with an evidence-based mindset."

Conditions treated:

  • All types of breast cancer (hormone receptor-positive, triple-negative, and HER2-positive)
  • Early-stage breast cancer
  • Metastatic breast cancer
  • Carcinoma in situ of the breast 

Procedures performed:

  • Chemotherapy
  • Chemoimmunotherapy
  • Targeted therapies
  • Immunotherapy
  • Endocrine therapies
  • Clinical trials 

Area(s) of expertise:

  • Breast cancer (hormone receptor-positive, triple-negative, and HER2/neu-positive)
  • Carcinoma in situ of the breast
  • Clinical trials

Research interests:

  • Endocrine resistance-immunotherapies
  • Clinical trials
  • New drug development

  • Fellowship Program: National Institute of Health (2019)
  • Residency Program: Tulane University Medical Center (2016)
  • Residency Program: Tulane University (2016)
  • Medical School: Tulane University (2013)
    MedStar Health Providers participate with a wide range of health insurance products. We accept self-pay patients and the insurances plans listed below. This list is not comprehensive, it is updated periodically and is subject to change. If you do not see your health insurance plan or product listed, or if you have any questions regarding MedStar Health’s participation with your health plan, please contact your health plan to verify participation with our providers.

    Since the MedStar Health providers span the District of Columbia, Maryland and Virginia regions, our participation with DC, Maryland and Virginia Medical Assistance programs varies by provider group. Please contact your MedStar Physician’s Office to assist with verifying Medical Assistance participation. If you are enrolled in a Medicaid Managed Care Organization, please contact your Medicaid health plan to verify participation.

Practice Locations
  • 3800 Reservoir Road Northwest
    Washington, DC 20007
    View Map

Member of Medical Staff
  • MedStar Georgetown University Hospital
  • Academic Achievement Award, National Cancer Institute, 2019
  • Merit Award, Conquer Cancer Foundation of ASCO, 2019            
  • Travel Award, 5th Annual Immuno-Oncology Young Investigators’ Forum, 2019
  • Travel Award, SITC Cancer Immunotherapy Winter School, 2019
  • Academic Achievement Award, National Cancer Institute, 2018
  • Merit Award, Conquer Cancer Foundation of ASCO, 2018
  • AACR/ASCO Methods in Clinical Cancer Research Workshop (Vail, CO), 2018
  • The Department of Medicine Chairman’s Award, Tulane University School of Medicine, 2013